Bank of Montreal Can Has $269,000 Stock Position in Premier, Inc. (NASDAQ:PINC)

Bank of Montreal Can lessened its holdings in Premier, Inc. (NASDAQ:PINC) by 49.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,699 shares of the company’s stock after selling 12,591 shares during the quarter. Bank of Montreal Can’s holdings in Premier were worth $269,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Brooklyn Investment Group boosted its stake in Premier by 61,750.0% in the fourth quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock valued at $26,000 after buying an additional 1,235 shares in the last quarter. SRS Capital Advisors Inc. lifted its holdings in shares of Premier by 157.8% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock worth $27,000 after acquiring an additional 786 shares during the last quarter. Keystone Financial Group Inc. bought a new position in shares of Premier in the fourth quarter worth about $37,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Premier in the 3rd quarter valued at approximately $39,000. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Premier by 297.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock valued at $40,000 after purchasing an additional 1,427 shares during the last quarter. Institutional investors own 74.41% of the company’s stock.

Analyst Upgrades and Downgrades

PINC has been the topic of a number of research reports. Robert W. Baird decreased their target price on shares of Premier from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Piper Sandler reduced their price objective on Premier from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Finally, Canaccord Genuity Group dropped their target price on Premier from $21.00 to $19.00 and set a “hold” rating for the company in a research report on Wednesday, February 5th. Eight equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $20.17.

Premier Trading Up 1.0 %

NASDAQ PINC opened at $19.99 on Friday. The firm has a market capitalization of $1.83 billion, a PE ratio of -199.88 and a beta of 0.51. The business’s 50-day moving average price is $18.83 and its two-hundred day moving average price is $20.41. Premier, Inc. has a 12 month low of $17.23 and a 12 month high of $23.56.

Premier Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Sunday, June 15th. Shareholders of record on Sunday, June 1st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 4.20%. Premier’s dividend payout ratio is presently -840.00%.

Insiders Place Their Bets

In other Premier news, General Counsel David L. Klatsky sold 10,000 shares of the company’s stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $19.53, for a total transaction of $195,300.00. Following the sale, the general counsel now owns 90,597 shares of the company’s stock, valued at approximately $1,769,359.41. This represents a 9.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.96% of the company’s stock.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.